Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
C. Nicolaides(University Hospital of Ioannina), Nikolaos Pavlidis(University Hospital of Ioannina), George Fountzilas(Hellenic Cooperative Oncology Group), Haralabos P. Kalofonos(University of Patras), Esma Razi(Hygeia Hospital), Dimitrios Bafaloukos(Metropolitan Hospital), E. Samantas(Hospital Agioi Anargyroi), P. Kosmidis(Hygeia Hospital), Meletios Α. Dimopoulos(Korea University)
Cited by 50
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k